Abstract: A computer-implemented method for use in decoding syndromes of a quantum error correction code, the syndromes comprising measurement data from a quantum computer comprising a plurality of syndrome qubits and a plurality of data qubits.

Abstract: A decoder apparatus for decoding syndromes of a quantum error correction code, the syndromes comprising measurement data from a quantum computer, the quantum computer comprising an array of qubits including syndrome qubits and data qubits. The decoder apparatus is configured to: receive syndrome index data representative of: a physical location of each of the array of qubits within the quantum computer; and lattice dimensions of the array of qubits; receive the syndromes of the quantum error correction code from the quantum computer; determine physical co-ordinate positions for each of the array of qubits based on the syndrome index data; decode the syndromes of the quantum error correction code using the determined physical co-ordinate positions.

Abstract: A disposable protective bib comprises a generally rectangular sheet of flexible, liquid-impervious material. The bib has a top portion comprising a yoke to accommodate the user's neck and a bottom portion comprising at least one fastening element for securing the bib to a table. The bib forms a pocket between the wearer and the table to catch food and beverages that may be spilled. The yoke comprises at least one perforated tear section to release the bib from the wearer.

Abstract: The instant invention relates to the use of compounds that are effective as selective opiate receptor modulators for the manufacture of pharmaceuticals for the diagnosis and/or the treatment of disorders, said disorders being selected from eating disorders and digestive disorders, especially psychogenic eating disorders, for the manufacture of a pharmaceutical effective for modulating, the gastrointestinal tonus, and to pharmaceutical composition, comprising one or more of said modulator compounds and one or more compounds that are effective as appetite depressant.

Abstract: The invention relates to a gas fired vented heater preferably having a relatively thin profile adapted for mounting on or in a wall structure and having a heat radiant display surface with visible decorative refractory defining a rear wall of the combustion chamber.

Abstract: A system for modeling a physical system comprises an interface configured to receive user inputs defining an adjustment mode and an amplitude for modifying a time history of a physical system, and a calculation engine configured to receive the time history of the physical system, modify the time history based on the defined adjustment and the amplitude, and output the modified time history, which is used to build a modified model of the physical system. The adjustment mode comprises a function template and a basis function.

Abstract: An apparatus and method for forming a RAM data memory that generates predictable noise/interference components that are coherent with each write cycle and essentially independent of the data content of the RAM data memory. The RAM data memory is comprised of a plurality of cells, each representing a data bit, which are selectively addressable as memory bytes formed of multiple bits. Each cell is formed of two sets of cross-coupled transistors. By causing each set of cross-coupled transistors to be set to a common voltage level at the beginning of a write cycle before setting one set of transistors to a low level and the one set of transistors to be set to a high level (thus representing a desired data bit value), the associated noise/interference components of the power drain are data independent. Furthermore, the data-independent noise occurs at frequencies at or above the write cycle rate.

Abstract: Piperidine derivatives of the formula I and their physiologically acceptable salts in which X, Y, Z, R1, R2, R3 and R4 are as defined in claim 1 can be as excitatory amino acid antagonists for combating neurodegenerative disorders including cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's disease, cerebral ischaemias, infarcts and psychosis.

Abstract: A ceramic hearth burner comprising a cast ceramic main body arranged to be situated within a fire place. The main body has a first chamber and a second chamber. A combustion air regulator is arranged to regulate the amount of air into the first chamber and an outlet is arranged for controlling the flow of fuel into the second chamber. An ignition plate encloses the second chamber which has a plurality of holes for releasing the fuel therein into an ignition area. At least one portal is arranged to channel the combustion air from the first chamber into the ignition area. The regulator is actuated by differential pressure in the ignition area and in the outside air, the pressure in the ignition area being varied by the amount of fuel being ignited.

Abstract: A communication protocol that is configured to extend the battery life of devices that monitor and/or affect body parameters and is particularly useful in a system comprised of a system control unit (SCU) and one or more implanted devices. Each such implanted device is configured to be monitored and/or controlled by the SCU via a wireless communication channel. The time between battery rechargings is determined by the battery capacity and the device's power consumption. Accordingly, the present invention reduces their average power consumption by reducing the usage duty cycle of their power consuming transmit and receive modes used to communicate with the SCU. By dedicating addressable time slots to each of the implantable devices in the system and limiting their use of receive and transmit modes to time periods proximate to these time slots, the average power consumption is accordingly reduced.

Abstract: The invention relates to piperidine derivatives of the formula I in which R1, R2, m and k have the meanings indicated in claim 1, and their salts, novel intermediates and processes for the preparation of the compounds according to the invention. The compounds of the formula I are potent a receptor ligands and show 5-HT reuptake-inhibiting actions and can be used for the production of medicaments, for example for the treatment of disorders of the central nervous system, of strokes, brain or bone marrow traumata or of ischaemic states.

Abstract: The invention relates to a novel heat-stable form of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diph enylacetamide and to a process for the preparation and isolation of this compound in this novel form and to use for the production of medicaments which contain this compound and/or one of its physiologically acceptable salts.

Abstract: Disclosed herein are pharmaceutical preparations which are suitable for the treatment of postoperative ileus and contain at least one compound of the formula I ##STR1## in which R.sup.1 is Ar, cycloalkyl having 3-7 C atoms or cycloalkylalkyl having 4-8 C atoms,R.sup.2 is Ar, orR.sub.1 and R.sup.2 together are ##STR2## R.sup.3 is H, OH, OA or A, R.sup.4 is A or phenyl which can optionally be mono- or disubstituted by Hal, OH, OA, CF.sub.3, NO.sub.2, NH.sub.2, NHA, NHCOA, NHSO.sub.2 A and/or NA.sub.2,R.sup.5 is OH, CH.sub.2 OH,R.sup.6 and R.sup.7 in each case independently of one another are H, Hal, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA, NHCONH.sub.2, NO.sub.2 or methylenedioxy, with the oxy groups bonded to adjacent carbons on the ring,A is alkyl having 1-7 C atoms,Ar is a mono- or bicyclic aromatic radical which can optionally contain an N, O or S atom in the ring and can be mono-, di- or trisubstituted by A, Hal, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA and/or NHCONH.sub.2,D is CH.sub.

Abstract: Pharmaceutical preparations which are suitable for the treatment of inflammatory bowel disorders and contain at least one compound of the formula I ##STR1## in which R.sup.1 is Ar, cycloalkyl having 3-7 C atoms or cycloalkylalkyl having 4-8 C atoms,R.sup.2 is Ar, orR.sup.1 and R.sup.2 together are ##STR2## R.sup.3 is H, OH, OA or A, R.sup.4 is A or phenyl which can optionally be mono- or disubstituted by Hal, OH, OA, CF.sub.3, NO.sub.2, NH.sub.2, NHA, NHCOA, NHSO.sub.2 A and/or NA.sub.2,R.sup.5 is OH, CH.sub.2 OH,R.sup.6 and R.sup.7 in each case independently of one another are H, Hal, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA, NHCONH.sub.2, NO.sub.2 or methylenedioxy, with the oxy groups bonded to adjacent carbons on the ring,A is alkyl having 1-7 C atoms,Ar is a mono- or bicyclic aromatic radical which can optionally contain an N, O or S atom in the ring and can be mono-, di- or trisubstituted by A, Hal, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA and/or NHCONH.sub.2,D is CH.sub.

Abstract: Novel arylacetamides of the formula I ##STR1## in which Q is R.sup.4 --CH(CH.sub.2 Z)--NA--, ##STR2## R.sup.1 is Ar, cycloalkyl with 3-7 C atoms or C.sub.4 -C.sub.8 -cycloalkyl-C.sub.1 -C.sub.7 -alkyl,R.sup.2 is Ar,R.sup.3 is H, OH, OA or A,R.sup.4 is A or phenyl which can optionally be substituted once or twice by F, Cl, Br, I, OH, OA, CF.sub.3, NO.sub.2, NH.sub.2, NHA, NHCOA, NHSO.sub.2 A or NA.sub.2,R.sup.5 and R.sup.6 are each, independently of one another, H, F, Cl, Br, I, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA, NHCONH.sub.2, NO.sub.2 or taken together are methylenedioxy,A is alkyl with 1-7 C atoms, and physiologically acceptable salts thereof.

Abstract: Novel acetamides of the formula I ##STR1## in which Q, R, X and Y have the meanings defined herein, have analgesic and neuroprotective properties and bind with high affinity to kappa receptors.

Abstract: New analgesic compositions containing a compound of the formula I ##STR1## wherein .dbd.A--B.dbd. is .dbd.CH--CH.dbd. or --N--CR.sup.2 .dbd.,Alk is an alkylene group having 2-4 C atoms,R.sup.1 is H, dialkylaminoalkyl, carboxyalkyl, alkoxycarbonylalkyl, carbamoylalkyl, N-alkylcarbamoylalkyl or N,N-dialkylcarbamoylalkyl,Y is CH or N,Z is a bond or --CO--,Ar is a phenyl, thienyl or pyridyl group which is unsubstituted or substituted one or more times by alkyl, alkoxy, F, Cl, Br, I and/or CF.sub.3, andR.sup.2 is H, alkyl, alkoxy or alkylthio,in which the alkyl, alkoxy and alkylthio groups each contain 1-4 C atoms, and/or one of its physiologically acceptable salts.

Abstract: A multichannel FM subcarrier broadcast system is disclosed which enables the transmission of multiple independent signals by generating independent sidebands of suppressed carriers in the subcarrier band of an FM transmitting station. Transmitting and receiving apparatus is disclosed which employs phase shift networks to minimize interchannel distortion, thus allowing close spacing of adjacent sidebands.